Bellevue Group AG
- SEC CIK
- 0001674546
- Latest filing
- Aug 14, 2026
CSTL holding history
Castle Biosciences Inc in every 13F filed by Bellevue Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CSTL overviewAll 13F holders of CSTLFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −301,103−100.0% | Sold out | Holders |
| Q1 2025 | 301,103 | $6.03M | 0.1% | −444,879−59.6% | Reduced | Holders |
| Q4 2024 | 745,982 | $19.9M | 0.4% | −516,048−40.9% | Reduced | Holders |
| Q3 2024 | 1,262,030 | $36.0M | 0.6% | +44,929+3.7% | Added | Holders |
| Q2 2024 | 1,217,101 | $26.5M | 0.4% | −2,984−0.2% | Reduced | Holders |
| Q1 2024 | 1,220,085 | $27.0M | 0.4% | −12,293−1.0% | Reduced | Holders |
| Q4 2023 | 1,232,378 | $26.6M | 0.4% | +4,347+0.4% | Added | Holders |
| Q3 2023 | 1,228,031 | $20.7M | 0.3% | +103,988+9.3% | Added | Holders |
| Q2 2023 | 1,124,043 | $15.4M | 0.2% | +175,165+18.5% | Added | Holders |
| Q1 2023 | 948,878 | $21.6M | 0.3% | +4,566+0.5% | Added | Holders |
| Q4 2022 | 944,312 | $22.2M | 0.3% | +2,441+0.3% | Added | Holders |
| Q3 2022 | 941,871 | $24.6M | 0.4% | +812+0.1% | Added | Holders |
| Q2 2022 | 941,059 | $20.7M | 0.3% | +333,445+54.9% | Added | Holders |
| Q1 2022 | 607,614 | $27.3M | 0.3% | +607,614 | New | Holders |